1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Lysovant: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis Tonabacase (LSVT-1701) - Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder) | Phase 2 | Withdrawn | Lysovant | 2022-05-01 | 2022-06-30 |
Endocarditis (1)
United States (1)